Read this article:
Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress

Go here to see the original:
AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center

Go here to see the original:
ExCellThera announces submission of Drug Master File for UM171

Read the original here:
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Originally posted here:
Neurona Therapeutics to Present Preclinical Data Supporting Regenerative Cell Therapy, NRTX-1001, in Clinical Development for Chronic Focal Epilepsy,...

Read the original:
Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

See the article here:
Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention

See the rest here:
Vaxart Announces Adjournment of Annual Meeting of Stockholders

See the original post here:
Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms

Go here to see the original:
MacroGenics to Participate in Upcoming Investor Conference

Go here to see the original:
Genmab to Participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference

Original post:
Iovance Biotherapeutics to Present at Upcoming Conferences

See more here:
HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress

Here is the original post:
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene

Read more here:
Terns Pharmaceuticals to Present Clinical Data on Multiple NASH Programs at the EASL International Liver Congress 2022

Read the rest here:
Celularity To Be Added To The Russell 3000® Index And The Small-Cap Russell 2000®

Go here to see the original:
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology

Visit link:
European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer

View post:
Correction: Orphazyme Announces Publication of 2021 Financial Results and Annual Report

Excerpt from:
Societal CDMO Reports Inducement Grants for New Staff